• Isorhamnetin for Reliable Cell Assays

  2026-08-23

  This scenario-based guide explains how Isorhamnetin, SKU N1358, can be incorporated into cell viability, proliferation, apoptosis, and oxidative stress workflows. It connects the defined compound format and handling requirements with published porcine oocyte data while clarifying assay controls, interpretation limits, and practical vendor-selection criteria.

• How Norovirus Co-opts NINJ1 for Selective Secretion

  2026-08-22

  Song et al. show that murine norovirus exploits the host membrane-rupture factor NINJ1 to release the viral immune-modulatory protein NS1 through an unconventional secretion pathway. The study links caspase-3 cleavage, NINJ1 recruitment to viral replication sites, and selective NS1 release to intestinal infection in mice, offering a mechanistic framework for viral control of programmed cell death.

• MG-132 Workflows for Apoptosis and Cell-Cycle Studies

  2026-08-21

  MG-132 provides a fast, tunable way to disrupt proteasome function for apoptosis assays, cell-cycle arrest studies, oxidative stress profiling, and cancer research. This guide connects practical dose-finding and handling choices with a reference model showing how proteasome inhibition can help separate RIPK3-dependent cell-death programs from inflammatory signaling.

• Gasdermin C Rewires PDAC Stemness and Immunity

  2026-08-20

  A 2024 Advanced Science study identifies Gasdermin C (GSDMC) as a transcriptional regulator of pancreatic ductal adenocarcinoma stemness, metastasis, and immune evasion through a pyroptosis-independent mechanism. The work links ADAM17-mediated cleavage and nuclear GSDMC fragments to CXCL9-dependent immune remodeling and improved responses to KRASG12D inhibition and PD-1 blockade.

• Isoproterenol Sulfate Dihydrate in Cardiac Models

  2026-08-20

  Isoproterenol sulfate dihydrate, also called Isoproterenol hemisulfate, is a water-soluble non-selective β-adrenergic agonist for controlled studies of beta-adrenergic receptor signaling. Its receptor activity makes it useful for probing cAMP/PKA responses in cardiac, respiratory, and human pacemaker models, but its non-selective pharmacology requires appropriate controls.

• Ibrexafungerp vs Caspofungin in Resistant C. auris

  2026-08-19

  Wiederhold et al. combined isolate-level susceptibility testing with a delayed-treatment murine model to evaluate ibrexafungerp against fluconazole-resistant Candida auris. The study found consistent in vitro activity and meaningful in vivo effects, supporting glucan synthase inhibition as a strategy for invasive candidiasis when therapy cannot begin immediately.

• (-)-JQ1: A Causal Control for BET Studies

  2026-08-19

  (-)-JQ1 is an inactive JQ1 stereoisomer that helps separate BET-dependent biology from stereochemistry-independent assay effects. This article develops a causal, cell-to-animal framework for using it in epigenetics research and cancer biology research.

• Ibrexafungerp Against Resistant Candida auris

  2026-08-18

  Wiederhold and colleagues combined susceptibility testing with a delayed-treatment murine model to evaluate ibrexafungerp against fluconazole-resistant Candida auris. The study found consistent in vitro activity and improved survival and kidney fungal burden outcomes with higher ibrexafungerp doses, supporting glucan synthase inhibition as a strategy for difficult invasive candidiasis.

• DRB Workflow for Transcriptional Elongation

  2026-08-18

  DRB provides an acute pharmacological way to interrogate RNA polymerase II elongation, CDK signaling, and transcript-production kinetics. Its greatest value is as an orthogonal perturbation alongside RNA-modification and translation assays, where careful vehicle control and time-resolved sampling improve interpretation.

• MG-132 Workflows for Proteasome and ROS Studies

  2026-08-17

  MG-132, also called Z-LLL-al, provides a practical way to connect proteasome inhibition with protein accumulation, oxidative stress, apoptosis, and cell-cycle phenotypes. This guide translates vascular organoid findings on UBR5 and TERT into controlled MG-132 experiments while preserving clear dose, timing, and troubleshooting logic.

• Mechanobiology Beyond Contractility: (-)-Blebbistatin

  2026-08-17

  Mechanical forces can activate signaling pathways independently of conventional ligands. This thought-leadership article examines how (-)-Blebbistatin, a reversible non-muscle myosin II inhibitor, can help translational researchers distinguish force generation from force sensing, using recent findings on mechanically activated GABAB receptors as a mechanistic case study.

• Cell Lysis Buffer for WB and IP in Chemoresistance

  2026-08-16

  Cell lysis buffer for WB and IP supports non-denaturing protein extraction for Western blot, immunoprecipitation, and co-immunoprecipitation. K1123 combines Tris-buffered saline, Triton X-100, and protease and phosphatase inhibitors to help preserve protein abundance, phosphorylation, and native protein interactions during sample preparation.

• Aztreonam Workflows for Gram-Negative Research

  2026-08-15

  Aztreonam enables focused studies of cell-wall inhibition, Gram-negative resistance, and exposure-linked cellular effects. This guide connects broth microdilution, plasmid-transfer analysis, bone marrow progenitor assays, and hepatic microsome workflows while separating established findings from practical assay recommendations.

• Moxidectin–Polyene Synergy in Oral Candidiasis

  2026-08-15

  A 2024 study found that Moxidectin enhances amphotericin B and nystatin activity against Candida albicans by increasing fungal ergosterol biosynthesis and polyene binding. Genetic, biochemical, and mouse-model data support a target-amplification strategy for oral candidiasis, although clinical translation remains unproven.

• Moxidectin B3611 for Reliable Cell Assays

  2026-08-14

  This scenario-driven guide shows how Moxidectin (SKU B3611) can support better-controlled antifungal, viability, proliferation, and cytotoxicity workflows. It connects recent Candida albicans evidence with practical decisions about solvent controls, assay interpretation, storage, and product reliability.

451 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page